Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Novos obesity version of semaglutide (at a higher dose) is marketed as Wegovy and was approved in 2021
Understanding correct injection technique ensures optimal treatment outcomes, minimises side effects, and supports long-term adherence to these subcutaneous therapies used for type 2 diabetes and weight management
Critical storage note: both compounds require refrigeration after reconstitution
Each BPC-157 batch undergoes heavy-metal and endotoxin screening to ensure it is free from hidden contaminants
US$ 23.72
US$ 28.82
US$ 20.59
US$ 25.92
US$ 23.89
US$ 29.76
